Cargando…

Microglial metabolic reconfiguration provides a new strategy for the treatment of Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Leng, Lige, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233783/ https://www.ncbi.nlm.nih.gov/pubmed/36926714 http://dx.doi.org/10.4103/1673-5374.367842

Ejemplares similares

Prothrombin kringle-2, a mediator of microglial activation: new insight in Alzheimer’s disease pathogenesis
por: Lee, Jae Man, et al.
Publicado: (2022)

Age-at-injury effects of microglial activation following traumatic brain injury: implications for treatment strategies
por: Raghupathi, Ramesh, et al.
Publicado: (2017)

The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
por: Bobkova, Natalia, et al.
Publicado: (2015)

Reconfigurable intelligent surface-empowered MIMO systems
por: Basar, Ertugrul
Publicado: (2023)

Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022)

Microglial depletion and repopulation: a new era of regenerative medicine?
por: Barnett, Alexandra M., et al.
Publicado: (2020)

Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease
por: Kim, Sang Ryong
Publicado: (2015)

Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease
por: Shapira, Ronit, et al.
Publicado: (2018)

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Metabolic Strategies in Healthcare: A New Era
por: Phillips, Matthew CL
Publicado: (2022)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

Microglial dynamics during brain development
por: Okajima, Tomomi, et al.
Publicado: (2018)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
por: Bano, Daniele, et al.
Publicado: (2023)

Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation
por: Zhang, Mo, et al.
Publicado: (2023)

Microglial exosomes in retinal neuroinflammation: focus in glaucoma
por: Aires, Inês Dinis, et al.
Publicado: (2021)

Exploring genes that control microglial heterogeneity and transition
por: Okajima, Tomomi, et al.
Publicado: (2021)

Acetylcholinesterase inhibitor modifications: a promising strategy to delay the progression of Alzheimer's disease
por: Bhattacharya, Soumee, et al.
Publicado: (2015)

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
por: Zheng, Honghua, et al.
Publicado: (2018)

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants
por: Bu, Guojun
Publicado: (2022)

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
por: Brunetti, Leonardo, et al.
Publicado: (2019)

Going beyond established model systems of Alzheimer’s disease: companion animals provide novel insights into the neurobiology of aging
por: de Sousa, Alexandra A., et al.
Publicado: (2023)

Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide neuroprotection in an Alzheimer's disease model: the case of Teline monspessulana
por: Fuentealba, Jorge, et al.
Publicado: (2014)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
por: Souchet, Benoit, et al.
Publicado: (2018)

Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
por: Lepiarz-Raba, Izabela, et al.
Publicado: (2023)

Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
por: Grossmann, Klaus
Publicado: (2021)

Myelin lipid deficiency: a new key driver of Alzheimer’s disease
por: Qiu, Shulan, et al.
Publicado: (2022)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
por: Liu, Ruiyuan, et al.
Publicado: (2019)

Microglial Immunometabolism in Alzheimer’s Disease
por: Shippy, Daniel C., et al.
Publicado: (2020)

Reconfiguring a One-Way Street: A Position Paper on Why and How to Improve Equity in Global Physician Training
por: Hudspeth, James C., et al.
Publicado: (2019)

Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
por: Tonali, Nicoló, et al.
Publicado: (2021)

Administration of pre/probiotics with conventional drug treatment in Alzheimer’s disease
por: Hort, Jakub, et al.
Publicado: (2019)

Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer’s disease
por: Guillot-Sestier, Marie-Victoire, et al.
Publicado: (2021)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer’s Disease
por: Li, Na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bnacln5b8o7ne13tje5t1nmumr